MedTrace Logo

The Role of Inflammation and Aging in HIV-Associated Cardiovascular Risk

NCT01333644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2015-06-02

No results posted yet for this study

Summary

It is the central hypothesis of the investigators study that HIV disease is a pro-inflammatory condition, and that years of inflammation result in premature "aging' of the immune system ("immunosenescence"). Just as these changes are thought be causally associated with heart disease in the very old,the investigators postulate that these changes will be associated with early heart disease in the untreated and perhaps treated HIV disease. To address this hypothesis, the investigators will measure immunosenescence in a large cohort of patients who span the entire disease process.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Priscilla Hsue, MD · University of California, San Francisco

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01333644 on ClinicalTrials.gov